A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Dominik Dytfeld Andrzej Jakubowiak Keith Stockerl-Goldstein |
| Publication date | June 4, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |